Cargando…
Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissue...
Autores principales: | Zorkina, Yana, Abramova, Olga, Ushakova, Valeriya, Morozova, Anna, Zubkov, Eugene, Valikhov, Marat, Melnikov, Pavel, Majouga, Alexander, Chekhonin, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697162/ https://www.ncbi.nlm.nih.gov/pubmed/33202839 http://dx.doi.org/10.3390/molecules25225294 |
Ejemplares similares
-
Intranasal neuropeptide Y is most effective in some aspects of acute stress compared to melatonin, oxytocin and orexin
por: Zubkov, Eugene, et al.
Publicado: (2022) -
The Behavior and Postnatal Development in Infant and Juvenile Rats After Ultrasound-Induced Chronic Prenatal Stress
por: Abramova, Olga, et al.
Publicado: (2021) -
Brain Metabolic Profile after Intranasal vs. Intraperitoneal Clomipramine Treatment in Rats with Ultrasound Model of Depression
por: Abramova, Olga, et al.
Publicado: (2021) -
Protein Misfolding and Aggregation in the Brain: Common Pathogenetic Pathways in Neurodegenerative and Mental Disorders
por: Ochneva, Aleksandra, et al.
Publicado: (2022) -
The Comparison of a New Ultrasound-Induced Depression Model to the Chronic Mild Stress Paradigm
por: Zorkina, Yana A., et al.
Publicado: (2019)